 | • レポートコード：MRC2302F0243 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、248ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年の206億ドルであった世界の心臓モニタリング・心調律管理（CRM）装置市場規模が、2022年に217億ドルへ達し、2027年までに年平均5.28%成長し、281億ドルへ拡大すると見込んでいます。本書は、心臓モニタリング・心調律管理（CRM）装置の世界市場を対象に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、心臓モニタリング装置別（心拍出量モニタリング装置、心電図装置、イベントモニター、体内埋め込み型ループレコーダー、その他）分析、心調律管理（CRM）装置別（除細動器、ペースメーカー）分析、エンドユーザー別（外来手術センター、病院・診療所・心臓センター）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目について調査・分析を行っています。また、市場調査の対象企業には、Abbott Laboratories、Abiomed、ACS Diagnostics、Alivecor, Inc.、Amiitalia、Asahi Kasei Corporation、Bexen Cardio、Biotelemetry、Biotronikなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の心臓モニタリング・心調律管理（CRM）装置市場規模：心臓モニタリング装置別 - 心拍出量モニタリング装置の市場規模 - 心電図装置の市場規模 - イベントモニターの市場規模 - 体内埋め込み型ループレコーダーの市場規模 - その他心臓モニタリング装置の市場規模 ・世界の心臓モニタリング・心調律管理（CRM）装置市場規模：心調律管理（CRM）装置別 - 除細動器の市場規模 - ペースメーカーの市場規模 ・世界の心臓モニタリング・心調律管理（CRM）装置市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 病院・診療所・心臓センターにおける市場規模 ・世界の心臓モニタリング・心調律管理（CRM）装置市場規模：地域別 - 南北アメリカの心臓モニタリング・心調律管理（CRM）装置市場規模 アメリカの心臓モニタリング・心調律管理（CRM）装置市場規模 カナダの心臓モニタリング・心調律管理（CRM）装置市場規模 ブラジルの心臓モニタリング・心調律管理（CRM）装置市場規模 ... - アジア太平洋の心臓モニタリング・心調律管理（CRM）装置市場規模 日本の心臓モニタリング・心調律管理（CRM）装置市場規模 中国の心臓モニタリング・心調律管理（CRM）装置市場規模 インドの心臓モニタリング・心調律管理（CRM）装置市場規模 韓国の心臓モニタリング・心調律管理（CRM）装置市場規模 台湾の心臓モニタリング・心調律管理（CRM）装置市場規模 ... - ヨーロッパ/中東/アフリカの心臓モニタリング・心調律管理（CRM）装置市場規模 イギリスの心臓モニタリング・心調律管理（CRM）装置市場規模 ドイツの心臓モニタリング・心調律管理（CRM）装置市場規模 フランスの心臓モニタリング・心調律管理（CRM）装置市場規模 ロシアの心臓モニタリング・心調律管理（CRM）装置市場規模 ... - その他地域の心臓モニタリング・心調律管理（CRM）装置市場規模 ・競争状況 ・企業情報 |
The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market size was estimated at USD 20.60 billion in 2021 and expected to reach USD 21.65 billion in 2022, and is projected to grow at a CAGR 5.28% to reach USD 28.05 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cardiac Monitoring & Cardiac Rhythm Management Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Cardiac Monitoring Devices, the market was studied across Cardiac Output Monitoring Devices, Ecg Devices, Event Monitors, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, and Smart Ecg Monitors. The Ecg Devices is further studied across Holter Monitors, Resting Ecg Devices, and Stress Ecg Devices. The Event Monitors is further studied across Post-Symptom Event Monitors and Pre-Symptom Event Monitors.
Based on Cardiac Rhythm Management Devices, the market was studied across Defibrillators and Pacemakers. The Defibrillators is further studied across External Defibrillators and Implantable Cardioverter Defibrillators. The External Defibrillators is further studied across Automated External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators. The Implantable Cardioverter Defibrillators is further studied across Subcutaneous Implantable Cardioverter Defibrillators and Transvenous Implantable Cardioverter Defibrillators (T-Icds). The Pacemakers is further studied across Biventricular/Crt Pacemakers, Dual-Chamber Pacemakers, and Single-Chamber Pacemakers.
Based on End User, the market was studied across Ambulatory Surgery Centers and Hospitals, Clinics, & Cardiac Centers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cardiac Monitoring & Cardiac Rhythm Management Devices market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, including Abbott Laboratories, Abiomed, ACS Diagnostics, Alivecor, Inc., Amiitalia, Asahi Kasei Corporation, Bexen Cardio, Biotelemetry, Biotronik, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies, BTL, GE Healthcare, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., Lepu Medical Technology, Medtronic, PLC, Metrax Gmbh, Microport Scientific Corporation, Narang Medical Limited, Nihon Kohden Corporation, Osypka AG, Progetti Srl, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shree Pacetronix, and Zoll Medical Corporation.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market?
4. What is the competitive strategic window for opportunities in the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market?
5. What are the technology trends and regulatory frameworks in the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market?
6. What is the market share of the leading vendors in the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market?
7. What modes and strategic moves are considered suitable for entering the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased prevalence and awareness about cardiovascular disease
5.1.1.2. Attractive reimbursement option in developed economies
5.1.1.3. Launch of innovative and portable devices by market players
5.1.1.4. Increasing investments and funds
5.1.2. Restraints
5.1.2.1. Frequent product recalls
5.1.2.2. Dearth of skilled professionals
5.1.3. Opportunities
5.1.3.1. Increased availability of wearable and sensor based devices
5.1.3.2. Measures to reduce infections caused due to CIEDs
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements delaying the approval of cardiac devices
5.2. Cumulative Impact of COVID-19
6. Cardiac Monitoring & Cardiac Rhythm Management Devices Market, by Cardiac Monitoring Devices
6.1. Introduction
6.2. Cardiac Output Monitoring Devices
6.3. Ecg Devices
6.4.1. Holter Monitors
6.4.2. Resting Ecg Devices
6.4.3. Stress Ecg Devices
6.4. Event Monitors
6.5.1. Post-Symptom Event Monitors
6.5.2. Pre-Symptom Event Monitors
6.5. Implantable Loop Recorders
6.6. Mobile Cardiac Telemetry Devices
6.7. Smart Ecg Monitors
7. Cardiac Monitoring & Cardiac Rhythm Management Devices Market, by Cardiac Rhythm Management Devices
7.1. Introduction
7.2. Defibrillators
7.3.1. External Defibrillators
7.3.2.1. Automated External Defibrillators
7.3.2.2. Manual External Defibrillators
7.3.2.3. Wearable Cardioverter Defibrillators
7.3.2. Implantable Cardioverter Defibrillators
7.3.3.1. Subcutaneous Implantable Cardioverter Defibrillators
7.3.3.2. Transvenous Implantable Cardioverter Defibrillators (T-Icds)
7.3. Pacemakers
7.4.1. Biventricular/Crt Pacemakers
7.4.2. Dual-Chamber Pacemakers
7.4.3. Single-Chamber Pacemakers
8. Cardiac Monitoring & Cardiac Rhythm Management Devices Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals, Clinics, & Cardiac Centers
9. Americas Cardiac Monitoring & Cardiac Rhythm Management Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Abiomed
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. ACS Diagnostics
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Alivecor, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Amiitalia
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Asahi Kasei Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Bexen Cardio
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Biotelemetry
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Biotronik
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Biotronik SE & Co KG
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Boston Scientific Corporation
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. BPL Medical Technologies
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. BTL
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. GE Healthcare
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Hill-Rom Holdings, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Koninklijke Philips N.V.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Lepu Medical Technology
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Medtronic, PLC
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Metrax Gmbh
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Microport Scientific Corporation
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Narang Medical Limited
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Nihon Kohden Corporation
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Osypka AG
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Progetti Srl
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Schiller AG
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services
13.27. Shree Pacetronix
13.27.1. Business Overview
13.27.2. Key Executives
13.27.3. Product & Services
13.28. Zoll Medical Corporation
13.28.1. Business Overview
13.28.2. Key Executives
13.28.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing